M28 Capital Management’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-121,200
| Closed | -$4.19M | – | 10 |
|
|
2025
Q1 | $4.19M | Hold |
121,200
| – | – | 5.74% | 4 |
|
|
2024
Q4 | $3.33M | Hold |
121,200
| – | – | 3.27% | 7 |
|
|
2024
Q3 | $3.09M | Hold |
121,200
| – | – | 3.39% | 8 |
|
|
2024
Q2 | $3.07M | Hold |
121,200
| – | – | 3.98% | 7 |
|
|
2024
Q1 | $3.75M | Hold |
121,200
| – | – | 2.77% | 8 |
|
|
2023
Q4 | $4.89M | Hold |
121,200
| – | – | 4.05% | 7 |
|
|
2023
Q3 | $3.2M | Sell |
121,200
-45,000
| -27% | -$1.19M | 3.67% | 6 |
|
|
2023
Q2 | $2.86M | Sell |
166,200
-138,500
| -45% | -$2.38M | 3.78% | 9 |
|
|
2023
Q1 | $5.05M | Sell |
304,700
-114,300
| -27% | -$1.9M | 5.71% | 6 |
|
|
2022
Q4 | $3.19M | Sell |
419,000
-94,300
| -18% | -$719K | 3.04% | 8 |
|
|
2022
Q3 | $5.1M | Buy |
513,300
+47,100
| +10% | +$468K | 5.33% | 5 |
|
|
2022
Q2 | $4.23M | Hold |
466,200
| – | – | 4.75% | 5 |
|
|
2022
Q1 | $4.73M | Hold |
466,200
| – | – | 4.35% | 8 |
|
|
2021
Q4 | $7.78M | Buy |
+466,200
| New | +$7.78M | 6.07% | 7 |
|